Home › Asset managers › Compare 2025-2026 › American Century vs ProShares
American Century 2025-2026 · ProShares 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 26,123 | 24,929 | 1,050 | 144 | 96.0% | 95.7% |
| Board proposals | 23,824 | 22,789 | 917 | 118 | 96.1% | 95.9% |
| E&S shareholder proposals | 175 | 156 | 19 | 0 | 89.1% | 89.1% |
| Other items | 2,124 | 1,984 | 114 | 26 | 94.6% | 94.1% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
1,050 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | American Century | ProShares |
|---|---|---|---|---|---|---|
| NETAPP, INC. | September 10, 2025 | To approve a stockholder proposal regarding support for Special Shareholder Meeting Improvement. Shareholder Rights and Defenses |
Other | Against | FOR 7 funds |
AGAINST 20 funds |
| NETFLIX, INC. | June 4, 2026 | Stockholder proposal entitled, "Proposal 4 - Shareholder Right to Act by Written Consent," if properly presented at the meeting. Shareholder Rights and Defenses |
Other | Against | AGAINST 23 funds |
FOR 32 funds |
| NTT, Inc. | June 18, 2026 | Amend Articles to Ensure Equal Treatment of Management Proposals and Shareholder Proposals in Voting via the Internet Corporate Governance |
Other | Against | AGAINST 4 funds |
FOR 1 fund |
| NTT, Inc. | June 18, 2026 | Amend Articles to Relax Limit of Number of Characters in Shareholder Proposal Justification Statements Corporate Governance |
Other | Against | AGAINST 4 funds |
FOR 1 fund |
| PAPA JOHN'S INTERNATIONAL, INC. | April 30, 2026 | Stockholder proposal regarding special meeting ownership threshold, if properly presented at the meeting. Shareholder Rights and Defenses |
Other | Against | AGAINST 4 funds |
FOR 14 funds |
| PPG INDUSTRIES, INC. | April 16, 2026 | Shareholder proposal to adopt a policy requiring an independent board chair, if properly presented Corporate Governance |
Other | Against | AGAINST 13 funds |
FOR 21 funds |
| PRUDENTIAL FINANCIAL, INC. | May 12, 2026 | Shareholder proposal regarding an Independent Board Chairman. Corporate Governance |
Other | Against | AGAINST 10 funds |
FOR 18 funds |
| RESIDEO TECHNOLOGIES, INC. | June 3, 2026 | Shareholder Proposal Regarding Shareholder Right to Act by Written Consent. Shareholder Rights and Defenses |
Other | Against | AGAINST 4 funds |
FOR 14 funds |
| REVVITY, INC. | April 28, 2026 | To approve the shareholder proposal regarding Executives to Retain Significant Stock. Compensation |
Other | Against | AGAINST 4 funds |
FOR 19 funds |
| ROOT, INC. | June 3, 2026 | To approve an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended, to allow for exculpation of certain officers. Director Elections |
Other | For | FOR 4 funds |
AGAINST 9 funds |
| SELECT MEDICAL HOLDINGS CORPORATION | April 23, 2026 | Non-Binding Advisory Vote on a Company Proposal to provide stockholders the right to call a special meeting of stockholders at a 25% ownership threshold. Shareholder Rights and Defenses |
Other | For | FOR 1 fund |
AGAINST 12 funds |
| SELECT MEDICAL HOLDINGS CORPORATION | April 23, 2026 | Non-Binding Advisory Vote on a Stockholder Proposal to provide stockholders the right to call a special meeting of stockholders at a 10% ownership threshold, if properly presented at the meeting. Shareholder Rights and Defenses |
Other | Against | AGAINST 1 fund |
FOR 12 funds |
| SERVICE CORPORATION INTERNATIONAL | May 6, 2026 | To approve an amendment to the Articles of Incorporation to limit the liability of officers as permitted by law. Director Elections |
Other | For | FOR 5 funds |
AGAINST 10 funds |
| SERVICENOW, INC. | May 21, 2026 | Shareholder proposal regarding shareholder right to act by written consent. Shareholder Rights and Defenses |
Other | Against | AGAINST 16 funds |
FOR 21 funds |
| SYNOPSYS, INC. | April 16, 2026 | To vote on a stockholder proposal regarding 'stockholders' right to act by written consent, if properly presented at the meeting. Shareholder Rights and Defenses |
Other | Against | AGAINST 6 funds |
FOR 26 funds |
| TELEPHONE AND DATA SYSTEMS, INC. | May 21, 2026 | Approval of an amendment to the Company's Restated Certificate of Incorporation to provide for exculpation of officers Director Elections |
Other | For | FOR 6 funds |
AGAINST 12 funds |
| TEXAS INSTRUMENTS INCORPORATED | April 16, 2026 | Stockholder proposal to permit stockholders to act by written consent. Shareholder Rights and Defenses |
Other | Against | AGAINST 6 funds |
FOR 30 funds |
| TEXAS PACIFIC LAND CORPORATION | November 6, 2025 | To consider a non-binding stockholder proposal to reduce the ownership threshold for stockholders to call a special stockholder meeting from 25% to 10%. Shareholder Rights and Defenses |
Other | Against | FOR 7 funds |
AGAINST 18 funds |
| THE BOEING COMPANY | April 17, 2026 | Action by Written Consent. Shareholder Rights and Defenses |
Other | Against | AGAINST 5 funds |
FOR 23 funds |
| THE CIGNA GROUP | April 22, 2026 | Shareholder Proposal - Shareholder Right to Act by Written Consent Shareholder Rights and Defenses |
Other | Against | AGAINST 14 funds |
FOR 18 funds |
| THE ESTEE LAUDER COMPANIES INC. | November 13, 2025 | Approval of Amendments to the Restated Certificate of Incorporation to Eliminate the Monetary Liability of Certain Officers as Permitted by Delaware Law and to Make Certain Miscellaneous Changes to Article IV thereof. Director Elections |
Other | For | FOR 17 funds |
AGAINST 18 funds |
| THE HARTFORD INSURANCE GROUP, INC. | May 20, 2026 | Shareholder proposal that the Company adopt written consent rights for shareholders Shareholder Rights and Defenses |
Other | Against | AGAINST 11 funds |
FOR 18 funds |
| THE SHERWIN-WILLIAMS COMPANY | April 22, 2026 | Shareholder Proposal Regarding Shareholder Ability to Call a Special Meeting Shareholder Rights and Defenses |
Other | Against | AGAINST 6 funds |
FOR 22 funds |
| THE WESTERN UNION COMPANY | May 14, 2026 | Stockholder proposal regarding stockholder right to act by written consent Shareholder Rights and Defenses |
Other | Against | AGAINST 5 funds |
FOR 3 funds |
| UNITED AIRLINES HOLDINGS, INC. | May 19, 2026 | Advisory vote on stockholder proposal entitled "Shareholder Right to Act by Written Consent". Shareholder Rights and Defenses |
Other | Against | AGAINST 8 funds |
FOR 20 funds |
| VERISK ANALYTICS, INC. | May 19, 2026 | Shareholder Proposal - Shareholder Right to Act by Written Consent. Shareholder Rights and Defenses |
Other | Against | AGAINST 9 funds |
FOR 28 funds |
| VISA INC. | January 27, 2026 | Shareholder proposal on shareholder right to act by written consent. Shareholder Rights and Defenses |
Other | Against | AGAINST 18 funds |
FOR 23 funds |
| WALMART INC. | June 4, 2026 | Request for Cumulative Voting for Board Elections Shareholder Rights and Defenses |
Other | Against | FOR 12 funds |
AGAINST 33 funds |
| WELLS FARGO & COMPANY | April 28, 2026 | Shareholder Proposal - Request for Board of Directors to Adopt Policy for an Independent Chair. Corporate Governance |
Other | Against | AGAINST 8 funds |
FOR 21 funds |
| WEST PHARMACEUTICAL SERVICES, INC. | May 4, 2026 | Shareholder proposal regarding an independent Board Chair policy. Corporate Governance |
Other | Against | AGAINST 12 funds |
FOR 19 funds |
| WOODWARD, INC. | January 28, 2026 | Approve an amendment to the Certificate of Incorporation to eliminate cumulative voting rights in the election of directors. Shareholder Rights and Defenses |
Other | For | AGAINST 5 funds |
FOR 7 funds |
| ZOETIS INC. | May 20, 2026 | Shareholder proposal to permit shareholder action by written consent. Shareholder Rights and Defenses |
Other | Against | AGAINST 17 funds |
FOR 20 funds |
| ZSCALER, INC. | January 12, 2026 | To vote on a non-binding stockholder proposal requesting the declassification of our board of directors. Shareholder Rights and Defenses |
Other | Against | AGAINST 12 funds |
FOR 11 funds |
| 10X GENOMICS, INC. | June 4, 2026 | A vote to approve, on a non-binding, advisory basis, the compensation of our named executive officers; Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 10 funds |
| 1ST SOURCE CORPORATION | April 23, 2026 | Approval of Amended 1982 Restricted Stock Award Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 9 funds |
| 1ST SOURCE CORPORATION | April 23, 2026 | Approval of Amended Strategic Deployment Incentive Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 9 funds |
| 4D MOLECULAR THERAPEUTICS, INC. | June 17, 2026 | Approval, on an advisory, non-binding basis, of the compensation of the Company's named executive officers (''say-on-pay vote''). Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 12 funds |
| A-MARK PRECIOUS METALS, INC. | November 12, 2025 | Advisory vote on executive compensation Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 9 funds |
| AAR CORP. | September 16, 2025 | Advisory proposal to approve our Fiscal Year 2025 executive compensation Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 12 funds |
| ABEONA THERAPEUTICS INC. | June 12, 2026 | To approve an increase in the number of shares reserved for issuance under the Second Amended and Restated Abeona Therapeutics Inc. 2023 Equity Incentive Plan from 8,400,000 to 11,500,000. Compensation |
Board | For | AGAINST 1 fund |
FOR 5 funds |
| ACADIA HEALTHCARE COMPANY, INC. | May 6, 2026 | Approve a second amendment to the Acadia Healthcare Company, Inc. Amended and Restated Incentive Compensation Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 3 funds |
| ACADIA PHARMACEUTICALS INC. | May 29, 2026 | To approve an amendment to the Company's 2024 Equity Incentive Plan to, among other things, increase the aggregate number of shares of common stock authorized for issuance under the plan by 5,209,670 shares. Compensation |
Board | For | AGAINST 6 funds |
FOR 15 funds |
| ACADIA PHARMACEUTICALS INC. | May 29, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 15 funds |
| ACADIAN ASSET MANAGEMENT INC. | June 11, 2026 | Approval of 2026 Equity Incentive Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 12 funds |
| ACCENDRA HEALTH, INC. | May 14, 2026 | Non-Binding advisory vote to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 9 funds |
| ACCENTURE PLC | January 28, 2026 | To approve the Amended and Restated Accenture plc 2010 Share Incentive Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 20 funds |
| ACCO BRANDS CORPORATION | May 19, 2026 | Approval of an amendment to the 2022 ACCO Brands Corporation Incentive Plan to increase the number of shares available for future grant and eliminate fungible share counting provisions with respect to new awards. Compensation |
Board | For | AGAINST 7 funds |
FOR 9 funds |
| ACCO BRANDS CORPORATION | May 19, 2026 | Approval, by non-binding advisory vote, of the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 9 funds |
| ACLARIS THERAPEUTICS, INC. | June 4, 2026 | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement accompanying the proxy card. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 10 funds |
| ACME UNITED CORPORATION | April 27, 2026 | Approval, by non-binding advisory vote, of the compensation of the named executive officers of the Company as described in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 9 funds |
| ADAPTHEALTH CORP. | June 18, 2026 | Say-on-Pay - Non-binding advisory vote to approve the compensation paid to AdaptHealth's named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 12 funds |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | June 5, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers as described in the proxy statement; Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 10 funds |
| ADTALEM GLOBAL EDUCATION INC. | November 12, 2025 | Say-on-pay: Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 12 funds |
| ADVANCED ENERGY INDUSTRIES, INC. | May 7, 2026 | Approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan; Compensation |
Board | For | FOR 6 funds |
AGAINST 16 funds |
| AEBI SCHMIDT HOLDING AG | May 21, 2026 | Election of Barend Fruithof as the Chair of the Board of Directors Corporate Governance |
Board | For | FOR 5 funds |
AGAINST 8 funds |
| AEHR TEST SYSTEMS | October 20, 2025 | Proposal to approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 9 funds |
| AEROVIRONMENT, INC. | September 25, 2025 | Management proposal to approve the amendment and restatement of the company's 2021 equity incentive plan Compensation |
Board | For | AGAINST 2 funds |
FOR 17 funds |
| AES CORP | April 29, 2026 | Approval, on an advisory basis, of the Company's executive compensation. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 19 funds |
| AGILYSYS, INC. | September 4, 2025 | Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers set forth in the attached Proxy Statement Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 12 funds |
| AGIOS PHARMACEUTICALS, INC. | June 18, 2026 | To approve an amendment to the Agios Pharmaceuticals, Inc. 2023 Stock Incentive Plan, as Amended, to increase the number of shares of common stock available thereunder by 2,000,000 shares. Compensation |
Board | For | AGAINST 6 funds |
FOR 12 funds |
| AGIOS PHARMACEUTICALS, INC. | June 18, 2026 | To vote, on an advisory basis, to approve the compensation paid to our named executive officers. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 12 funds |
| AIR LEASE CORPORATION | December 18, 2025 | Proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to the named executive officers of Air Lease Corporation in connection with the merger (the ''Compensation Proposal''). Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 4 funds |
| AKAMAI TECHNOLOGIES, INC. | May 13, 2026 | To approve an amendment to our Second Amended and Restated 2013 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 8,000,000 shares. Compensation |
Board | For | FOR 10 funds |
AGAINST 22 funds |
| ALARM.COM HOLDINGS, INC. | June 3, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 14 funds |
| ALEXANDER & BALDWIN, INC. | March 9, 2026 | To consider and vote on a proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to our named executive officers that is based on or otherwise relates to the merger. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 15 funds |
| ALIGN TECHNOLOGY, INC. | May 20, 2026 | Advisory Vote to Approve the Compensation of our Named Executive Officers Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 17 funds |
| ALLOGENE THERAPEUTICS, INC. | June 18, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 12 funds |
| ALLY FINANCIAL INC. | May 6, 2026 | Advisory vote on executive compensation. Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 7 funds |
| ALPHA & OMEGA SEMICONDUCTOR LTD | November 12, 2025 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as described in the Proxy Statement Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 14 funds |
| ALPHABET INC. | June 5, 2026 | Advisory vote to approve compensation awarded to named executive officers Say-on-Pay |
Board | For | FOR 26 funds |
AGAINST 35 funds |
| ALPHATEC HOLDINGS, INC. | June 10, 2026 | To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 9 funds |
| AMC GLOBAL MEDIA INC. | June 16, 2026 | Vote on Proposal to Approve the Company's Amended and Restated 2011 Stock Plan for Non-Employee Directors Compensation |
Board | For | AGAINST 7 funds |
FOR 9 funds |
| AMENTUM HOLDINGS, INC | February 6, 2026 | Advisory vote to approve the Company's named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| AMERESCO, INC. (AMRC) | June 4, 2026 | To approve on a non-binding advisory basis the compensation of our named executive officer as described in the Ameresco, Inc. Proxy Statement. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 9 funds |
| AMERICA'S CAR-MART, INC. | September 25, 2025 | To approve an advisory resolution regarding the Company's compensation of its named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 9 funds |
| AMERICAN AIRLINES GROUP INC. | June 10, 2026 | A proposal to approve the Amended and Restated 2023 Incentive Award Plan Compensation |
Board | For | AGAINST 2 funds |
FOR 7 funds |
| AMERICAN STATES WATER COMPANY | May 19, 2026 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 17 funds |
| AMERICAN STATES WATER COMPANY | May 19, 2026 | To approve the 2026 Stock Incentive Plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 17 funds |
| AMERICAN SUPERCONDUCTOR CORPORATION | July 25, 2025 | To approve, on an advisory basis, the compensation of AMSC's named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 9 funds |
| AMERICAN TOWER CORPORATION | May 20, 2026 | To approve the American Tower Corporation 2026 Equity Incentive Plan. Compensation |
Board | For | AGAINST 8 funds |
FOR 18 funds |
| AMERICAN VANGUARD CORPORATION | July 2, 2025 | Resolved, that the compensation paid to the Company's named executive officers, as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables and narrative discussion, is hereby approved. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 8 funds |
| AMERICAN WOODMARK CORPORATION | August 21, 2025 | To approve on an advisory basis the Company's executive compensation. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 11 funds |
| AMERICAN WOODMARK CORPORATION | October 30, 2025 | To approve, on an advisory (non-binding) basis, the compensation that will or may be paid to American Woodmark's named executive officers in connection with the transactions contemplated by the merger agreement; and Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 13 funds |
| AMICUS THERAPEUTICS, INC. | March 3, 2026 | To approve, on a non-binding, advisory basis, the payment of certain compensation that may be paid or become payable to Amicus' named executive officers that is based on or otherwise relates to the Merger. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 13 funds |
| AMPHASTAR PHARMACEUTICALS INC. | June 1, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 17 funds |
| AMPLITUDE, INC. | June 9, 2026 | The approval, on an advisory (non-binding) basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 9 funds |
| ANGIODYNAMICS, INC. | November 10, 2025 | Say-on-Pay - An advisory vote on the approval of compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 9 funds |
| ANI PHARMACEUTICALS, INC. | May 21, 2026 | To approve the Amended and Restated 2022 Stock Incentive Plan. Compensation |
Board | For | AGAINST 8 funds |
FOR 15 funds |
| ANI PHARMACEUTICALS, INC. | May 21, 2026 | To approve the compensation of the Company's named executive officers, on a non-binding, advisory basis. Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 15 funds |
| ANIKA THERAPEUTICS, INC. | June 18, 2026 | Advisory vote on the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 9 funds |
| ANIKA THERAPEUTICS, INC. | June 18, 2026 | Approval of the Amendment to the Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 9 funds |
| ANNEXON, INC. | June 11, 2026 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 12 funds |
| AON PLC | June 26, 2026 | Advisory resolution to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 17 funds |
| APA CORPORATION | May 21, 2026 | Advisory vote to approve the compensation of APA's named executive officers Say-on-Pay |
Board | For | AGAINST 12 funds |
FOR 18 funds |
| APOGEE ENTERPRISES, INC. | June 24, 2026 | APPROVAL OF THE APOGEE ENTERPRISES, INC. 2019 STOCK INCENTIVE PLAN, AS AMENDED AND RESTATED (2026) TO INCREASE THE NUMBER OF SHARES AUTHORIZED FOR AWARDS FROM 2,150,000 TO 2,950,000. Compensation |
Board | For | AGAINST 10 funds |
FOR 13 funds |
| APOGEE THERAPEUTICS, INC. | June 9, 2026 | Approval, on a non-binding advisory basis, of the compensation of our named executive officers as disclosed in the proxy statement. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 12 funds |
| APPFOLIO, INC. | June 12, 2026 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 8 funds |
| APPLIED OPTOELECTRONICS, INC. | June 4, 2026 | To approve the 2026 equity incentive plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 9 funds |
| AQUESTIVE THERAPEUTICS, INC. | June 10, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 1 fund |
FOR 12 funds |
| ARCBEST CORPORATION | April 24, 2026 | To approve the reincorporation of the Company to the State of Texas by conversion. Extraordinary Transactions |
Board | For | FOR 10 funds |
AGAINST 12 funds |
← Previous Page 2 of 11 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 13, 2026 from SEC Form N-PX filings.